Alpha-Synuclein Preserves Mitochondrial Fusion and Function in Neuronal Cells

Dysregulations of mitochondria with alterations in trafficking and morphology of these organelles have been related to Parkinson's disease (PD), a neurodegenerative disorder characterized by brain accumulation of Lewy bodies (LB), intraneuronal inclusions mainly composed of α-synuclein (α-syn) fibrils. Experimental evidence supports that α-syn pathological aggregation can negatively impinge on mitochondrial functions suggesting that this protein may be crucially involved in the control of mitochondrial homeostasis. The aim of this study was to assay this hypothesis by analyzing mitochondrial function and morphology in primary cortical neurons from C57BL/6JOlaHsd α-syn null and C57BL/6J wild-type (wt) mice. Primary cortical neurons from mice lacking α-syn showed decreased respiration capacity measured with a Seahorse XFe24 Extracellular Flux Analyzer. In addition, morphological Airyscan superresolution microscopy showed the presence of fragmented mitochondria while real-time PCR and western blot confirmed altered expression of proteins involved in mitochondrial shape modifications in the primary cortical neurons of α-syn null mice. Transmission electron microscopy (TEM) studies showed that α-syn null neurons exhibited impaired mitochondria-endoplasmic reticulum (ER) physical interaction. Specifically, we identified a decreased number of mitochondria-ER contacts (MERCs) paralleled by a significant increase in ER-mitochondria distance (i.e., MERC length). These findings support that α-syn physiologically preserves mitochondrial functions and homeostasis. Studying α-syn/mitochondria interplay in health and disease is thus pivotal for understanding their involvement in PD and other LB disorders.

[1]  M. Goedert,et al.  The Synucleinopathies: Twenty Years On , 2017, Journal of Parkinson's disease.

[2]  Michael J. Devine,et al.  α-Synuclein binds to the ER–mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP production , 2017, Acta Neuropathologica.

[3]  Jean-Claude Martinou,et al.  SLP‐2 is required for stress‐induced mitochondrial hyperfusion , 2009, The EMBO journal.

[4]  A. Young,et al.  Absence of α-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia , 2005, Journal of Neural Transmission.

[5]  C. Manzoni,et al.  Is Alpha-Synuclein Loss-of-Function a Contributor to Parkinsonian Pathology? Evidence from Non-human Primates , 2016, Front. Neurosci..

[6]  M. Brini,et al.  The Close Encounter Between Alpha-Synuclein and Mitochondria , 2018, Front. Neurosci..

[7]  He-Jin Lee,et al.  Clearance and deposition of extracellular alpha-synuclein aggregates in microglia. , 2008, Biochemical and biophysical research communications.

[8]  A. Lieberman,et al.  Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration , 2019, Acta Neuropathologica Communications.

[9]  E. Schon,et al.  A new role for α‐synuclein in Parkinson's disease: Alteration of ER–mitochondrial communication , 2015, Movement disorders : official journal of the Movement Disorder Society.

[10]  M. Giacomello,et al.  Protein Localization at Mitochondria-ER Contact Sites in Basal and Stress Conditions , 2017, Front. Cell Dev. Biol..

[11]  XiaoXiang Zhu,et al.  Mitofusin-2 triggers mitochondria Ca2+ influx from the endoplasmic reticulum to induce apoptosis in hepatocellular carcinoma cells. , 2015, Cancer letters.

[12]  A. Alaimo,et al.  Alpha-synuclein mitochondrial interaction leads to irreversible translocation and complex I impairment. , 2018, Archives of biochemistry and biophysics.

[13]  Masaki Tanaka,et al.  Brain region‐dependent differential expression of alpha‐synuclein , 2016, The Journal of comparative neurology.

[14]  Armin Giese,et al.  Inhibition of mitochondrial fusion by α‐synuclein is rescued by PINK1, Parkin and DJ‐1 , 2010, The EMBO journal.

[15]  P. Spano,et al.  Alpha-synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease , 2012, Brain Research.

[16]  Annalena Venneri,et al.  Review: Parkinson's disease: from synaptic loss to connectome dysfunction , 2016, Neuropathology and applied neurobiology.

[17]  A. Negro,et al.  α-Synuclein Controls Mitochondrial Calcium Homeostasis by Enhancing Endoplasmic Reticulum-Mitochondria Interactions* , 2012, The Journal of Biological Chemistry.

[18]  M. Morelli,et al.  NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson’s Disease , 2018, Cell Death & Disease.

[19]  C. Angelini,et al.  Regulation of ER‐mitochondria contacts by Parkin via Mfn2 , 2018, Pharmacological research.

[20]  R. Swerdlow,et al.  Complex I deficiency in Parkinson's disease frontal cortex , 2008, Brain Research.

[21]  E. Schon,et al.  Novel subcellular localization for α-synuclein: possible functional consequences , 2015, Front. Neuroanat..

[22]  S. Archer.  Mitochondrial dynamics--mitochondrial fission and fusion in human diseases. , 2013, The New England journal of medicine.

[23]  Z. Wszolek,et al.  Clinical Aspects of Familial Forms of Frontotemporal Dementia Associated with Parkinsonism , 2011, Journal of Molecular Neuroscience.

[24]  Y. Yoon,et al.  The short variant of the mitochondrial dynamin OPA1 maintains mitochondrial energetics and cristae structure , 2017, The Journal of Biological Chemistry.

[25]  N. Chen,et al.  Targeted Overexpression of α-Synuclein by rAAV2/1 Vectors Induces Progressive Nigrostriatal Degeneration and Increases Vulnerability to MPTP in Mouse , 2015, PloS one.

[26]  R. Nussbaum,et al.  Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein α-Synuclein*♦ , 2011, The Journal of Biological Chemistry.

[27]  David S. Park,et al.  Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial Fission* , 2009, Journal of Biological Chemistry.

[28]  D. Chan,et al.  Functions and dysfunctions of mitochondrial dynamics , 2007, Nature Reviews Molecular Cell Biology.

[29]  P. Spano,et al.  Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson’s Disease? , 2017, Genes.

[30]  Robert Burke,et al.  Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Chan,et al.  Mitochondrial dynamics–fusion, fission, movement, and mitophagy–in neurodegenerative diseases , 2009, Human molecular genetics.

[32]  G. K. Schierle,et al.  Mitochondrial degradation of amyloidogenic proteins — A new perspective for neurodegenerative diseases , 2019, Progress in Neurobiology.

[33]  P. Chinnery,et al.  Disturbed mitochondrial dynamics and neurodegenerative disorders , 2015, Nature Reviews Neurology.

[34]  Tingting Du,et al.  α-Synuclein amino terminus regulates mitochondrial membrane permeability , 2014, Brain Research.

[35]  M. Teitell,et al.  Measuring energy metabolism in cultured cells, including human pluripotent stem cells and differentiated cells , 2012, Nature Protocols.

[36]  Eric J. Murphy,et al.  Mitochondrial Lipid Abnormality and Electron Transport Chain Impairment in Mice Lacking α-Synuclein , 2005, Molecular and Cellular Biology.

[37]  M. Spillantini,et al.  Alpha-synuclein modulates NR2B-containing NMDA receptors and decreases their levels after rotenone exposure , 2015, Neurochemistry International.

[38]  Andrew J. F. Valente,et al.  A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture. , 2017, Acta histochemica.

[39]  Jun Liu,et al.  Extracellular signal-regulated kinase is involved in alpha-synuclein-induced mitochondrial dynamic disorders by regulating dynamin-like protein 1 , 2012, Neurobiology of Aging.

[40]  Wei He,et al.  Mitophagy in Parkinson’s Disease: Pathogenic and Therapeutic Implications , 2017, Front. Neurol..

[41]  N. Avadhani,et al.  Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain* , 2008, Journal of Biological Chemistry.

[42]  P. Spano,et al.  Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First? , 2015, Parkinson's disease.

[43]  C. Specht,et al.  Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice , 2001, BMC Neuroscience.

[44]  Victor Tapias,et al.  shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model. , 2015, The Journal of clinical investigation.

[45]  P. Hollenbeck.  Mitochondria and Neurotransmission: Evacuating the Synapse , 2005, Neuron.

[46]  M. Zeviani,et al.  Neuronal complex I deficiency occurs throughout the Parkinson’s disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage , 2018, Acta Neuropathologica.

[47]  E. Schon,et al.  α-Synuclein Is Localized to Mitochondria-Associated ER Membranes , 2014, The Journal of Neuroscience.

[48]  P. Sachdev,et al.  Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts , 2013, Translational Neurodegeneration.

[49]  G. Voeltz,et al.  Endoplasmic reticulum–mitochondria contacts: function of the junction , 2012, Nature Reviews Molecular Cell Biology.

[50]  M. Vila,et al.  Mitochondrial biology and Parkinson's disease. , 2012, Cold Spring Harbor perspectives in medicine.

[51]  S. Ravi,et al.  Bioenergetic adaptation in response to autophagy regulators during rotenone exposure , 2014, Journal of neurochemistry.

[52]  K. Luk,et al.  Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production , 2017, Cellular and Molecular Life Sciences.

[53]  T. Langer,et al.  OPA1 processing in cell death and disease – the long and short of it , 2016, Journal of Cell Science.

[54]  A. F. Schinder,et al.  αSynuclein control of mitochondrial homeostasis in human-derived neurons is disrupted by mutations associated with Parkinson’s disease , 2017, Scientific Reports.

[55]  U. Schlötzer-Schrehardt,et al.  Alpha-synuclein prevents the formation of spherical mitochondria and apoptosis under oxidative stress , 2017, Scientific Reports.